Rifampicin resistant tuberculosis
Clinical trials for Rifampicin resistant tuberculosis explained in plain language.
Never miss a new study
Get alerted when new Rifampicin resistant tuberculosis trials appear
Sign up with your email to follow new studies for Rifampicin resistant tuberculosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with Drug-Resistant TB: pretomanid dose study completed
Disease control CompletedThis study tested a single dose of the drug pretomanid in 32 children with rifampicin-resistant tuberculosis (TB). The goal was to see how the drug moves through the body and whether it is safe when added to their regular TB treatment. The children were monitored for 48 hours aft…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can newer tests match the gold standard for detecting Drug-Resistant TB?
Diagnosis CompletedThis study evaluates whether two newer line probe assays, the YD REBA MTB-MDR and Hain Genotype MTBDRplus V2, perform as well as the older Hain Genotype MTBDRplus V1 in detecting drug-resistant tuberculosis. Researchers will test stored, de-identified samples from adults with sym…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC